Literature DB >> 8406847

The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

M Scriba1, J S Ebrahim, T Schlott, H Eiffert.   

Abstract

Three human monoclonal immunoglobulin M antibodies against Borrelia burgdorferi, obtained from in vitro-stimulated peripheral blood lymphocytes, reacted in Western blots (immunoblots) with a prominent 39-kDa peptide and a faint band of approximately 66 kDa. Two of these antibodies showed bactericidal activity without addition of complement. All three antibodies were reactive in an enzyme immunoassay with cloned P39 (W.J. Simpson, M.E. Schrumpf, and T.G. Schwan, J. Clin. Microbiol. 28:1329-1337, 1990), suggesting that the target molecule of these antibodies is identical to the P39 protein. In addition, the majority of supernatants from human lymphocytes stimulated in vitro with crude B. burgdorferi antigen reacted in this assay, demonstrating that P39, although a minor component of B. burgdorferi, is an immunodominant antigen in these spirochetes. A fourth monoclonal antibody, reacting with OspA, also exhibited bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406847      PMCID: PMC281194          DOI: 10.1128/iai.61.10.4523-4526.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Authors:  J L Schmitz; R F Schell; S D Lovrich; S M Callister; J E Coe
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 2.  A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.

Authors:  M M Simon; U E Schaible; R Wallich; M D Kramer
Journal:  Immunol Today       Date:  1991-01

3.  Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi.

Authors:  W J Simpson; M E Schrumpf; T G Schwan
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.

Authors:  W J Simpson; W Burgdorfer; M E Schrumpf; R H Karstens; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB.

Authors:  H Eiffert; A Ohlenbusch; W Fehling; H Lotter; R Thomssen
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Use of peroxidase-labelled antigen for the detection of antibodies to Borrelia burgdorferi in human and animal sera.

Authors:  H Eiffert; H Lotter; R Thomssen
Journal:  Scand J Infect Dis       Date:  1991

7.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi.

Authors:  B Ma; B Christen; D Leung; C Vigo-Pelfrey
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Lyme disease assay which detects killed Borrelia burgdorferi.

Authors:  S M Callister; R F Schell; S D Lovrich
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.

Authors:  E Fikrig; S W Barthold; N Marcantonio; K Deponte; F S Kantor; R A Flavell
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more
  26 in total

1.  Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

Authors:  C L Croke; E L Munson; S D Lovrich; J A Christopherson; M C Remington; D M England; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.

Authors:  E L Munson; B K Du Chateau; D A Jobe; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

Authors:  S M Callister; D A Jobe; R F Schell; C S Pavia; S D Lovrich
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

4.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

5.  Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.

Authors:  Gabrielle Richard; C Roger MacKenzie; Kevin A Henry; Evgeny Vinogradov; J Christopher Hall; Greg Hussack
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

6.  BmpA is a surface-exposed outer-membrane protein of Borrelia burgdorferi.

Authors:  Anton V Bryksin; Alexandra Tomova; Henry P Godfrey; Felipe C Cabello
Journal:  FEMS Microbiol Lett       Date:  2010-05-20       Impact factor: 2.742

7.  Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.

Authors:  Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Borrelia burgdorferi BmpA is a laminin-binding protein.

Authors:  Ashutosh Verma; Catherine A Brissette; Amy Bowman; Brian Stevenson
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

9.  Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.

Authors:  R K Straubinger; Y F Chang; R H Jacobson; M J Appel
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Authors:  Matthew B Lawrenz; R Mark Wooten; James F Zachary; Scott M Drouin; Janis J Weis; Rick A Wetsel; Steven J Norris
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.